SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

ZIOPHARM Oncology Q3 EPS $(0.43) May Not Compare To $(0.09) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.09) by 377.78 percent. This is a 230.77 percent decrease over losses of $(0.13) per share

Benzinga · -

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.09) by 377.78 percent. This is a 230.77 percent decrease over losses of $(0.13) per share from the same period last year.